[Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)].
Nom du journal : Bull Cancer
Année : 2024
Volume : 111
Page de départ : 87-96
